UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050677
Receipt number R000057741
Scientific Title Gastric Tube versus Whole Stomach Reconstruction after Esophagectomy for Esophageal Cancer: A Randomized Controlled Trial
Date of disclosure of the study information 2023/03/26
Last modified on 2023/09/26 21:23:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Gastric Tube versus Whole Stomach Reconstruction after Esophagectomy for Esophageal Cancer: A Randomized Controlled Trial

Acronym

ATHLETE trial

Scientific Title

Gastric Tube versus Whole Stomach Reconstruction after Esophagectomy for Esophageal Cancer: A Randomized Controlled Trial

Scientific Title:Acronym

ATHLETE trial

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will compare the incidence of anastomotic leakage in narrow gastric tube reconstruction and whole stomach reconstruction. In addition, we will evaluate complications such as anastomotic stenosis, perioperative course, body weight change, QOL, etc. in both reconstruction methods in the short and medium term, and clarify the optimal gastric tube preparation method for reconstruction after esophagectomy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Incidence of anastomotic leakage

Key secondary outcomes

Occurrence rate of anastomotic stenosis
Occurrence rate of pneumonia
Occurrence rate of all postoperative complications
Occurrence rate of reflux esophagitis
QOL evaluation by EORTC QLQ-C30 and EORTC OES-18
Nutritional evaluation
Amount of blood loss
Postoperative hospital stay
Blood flow evaluation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

standard treatment group: narrow gastric tube reconstruction

Interventions/Control_2

experimental treatment group: whole stomach reconstruction

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients with thoracic esophageal cancer whose tumor does not extend to the cervical esophagus
2) Patients who are used the stomach as a reconstructed organ and undergo reconstruction by either the posterior mediastinal route or the retrosternal route
3) Patients undergoing anastomosis in the neck
4) Patients who undergo 2-field or 3-field dissection
5) Patients aged between 18 and 85 years old at the time of enrollment
6) Patients who have given informed consent

Key exclusion criteria

1) Patients judged to be unable to undergo either narrow gastric tube or whole stomach reconstruction due to intraoperative findings
2) Patients with serious complications (interstitial pneumonia or pulmonary fibrosis, difficult-to-control diabetes, ischemic heart disease requiring treatment, heart failure, etc.)
3) Patients with moderate or severe hepatic or renal dysfunction
4) Patients with cirrhosis or active hepatitis
5) Patients undergoing dialysis
6) Patients judged inappropriate by the attending physician

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Junya
Middle name
Last name Kitadani

Organization

Wakayama Medical University

Division name

Second Department of Surgery

Zip code

641-8510

Address

Kimiidera811-1, Wakayama, Japan

TEL

073-441-0613

Email

kitadani@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Junya
Middle name
Last name Kitadani

Organization

Wakayama Medical University

Division name

Second Department of Surgery

Zip code

641-8510

Address

Kimiidera811-1, Wakayama, Japan

TEL

073-441-0613

Homepage URL


Email

kitadani@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Wakayama Medical University

Address

Kimiidera 811-1, Wakayama, Japan

Tel

073-447-2300

Email

wa-rinri@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

和歌山県立医科大学附属病院


Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 01 Month 19 Day

Date of IRB

2023 Year 03 Month 06 Day

Anticipated trial start date

2023 Year 03 Month 27 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 26 Day

Last modified on

2023 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057741


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name